N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate, 98% (Content MsOH 15.2-18.2%)
cas: 1421373-66-1 — see every product listed under this CAS number, including other names
N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate, 98% (Content MsOH 15.2-18.2%) (CAS 1421373-66-1) is a chemical reagent available from Chemat. Available pack sizes: 100mg, 250mg, 1g, 5g, 25g. Offered by: BLDpharm.
| brand | BLDpharm |
|---|---|
| catalog number | BD295391-100mg |
| cas | 1421373-66-1 |
| size | 100mg |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| BLDpharm | 100mg | 314.36 Pln | |
| BLDpharm | 250mg | 480.97 Pln | |
| BLDpharm | 1g | 869.72 Pln | |
| BLDpharm | 5g | 2741.28 Pln | |
| BLDpharm | 25g | 9444.48 Pln |
properties
| purity | 98% (Content MsOH 15.2-18.2%) |
|---|---|
| delivery time | 1-2 weeks |
Osimertinib mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. It is used for treatment of EGFR T790M mutation positive non-small cell lung cancer. It has a role as an antineoplastic agent and an epidermal growth factor receptor antagonist. It contains an osimertinib(1+).
Source: ChEBI
| Molecular formula | C29H37N7O5S |
|---|---|
| Molecular weight | 595.7 g/mol |
| IUPAC name | N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid |
| InChIKey | FUKSNUHSJBTCFJ-UHFFFAOYSA-N |
| SMILES | CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O |
Computed by PubChem (NCBI)